We hoped these genes, especially the MFAP4, SPARCL1, EFEMP1, COX7A1, ABCA8 and MAMDC2, would be an effective biomarker for BLCA diagnostics. This evidence concerns the gene SPARCL1 and bladder transitional cell carcinoma.